Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005
Published online before print November 10, 2005, doi: 10.1161/01.RES.0000195844.31466.e9
A more recent version of this article appeared on December 9, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
97/12/1262    most recent
01.RES.0000195844.31466.e9v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukuda, K.
Right arrow Articles by Balser, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukuda, K.
Right arrow Articles by Balser, J. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arrhythmia
Hazardous Substances DB
*TERT-BUTYL HYDROPEROXIDE
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Ion channels/membrane transport
Right arrow Lipid and lipoprotein metabolism
Right arrow Oxidant stress

Submitted on May 24, 2005
Revised on October 17, 2005
Accepted on November 3, 2005

Oxidative Mediated Lipid Peroxidation Recapitulates Proarrhythmic Effects on Cardiac Sodium Channels

Koji Fukuda ; Sean S. Davies ; Tadashi Nakajima ; Boon-Hooi Ong ; Sabina Kupershmidt ; Joshua Fessel ; Venkataraman Amarnath ; Mark E. Anderson ; Penelope A. Boyden ; Prakash C. Viswanathan ; L. Jackson Roberts II ; and Jeffrey R. Balser *

From the Departments of Anesthesiology (K.F., T.N., B.-H.O., S.K., P.C.V., J.R.B.), Pharmacology (S.S.D., J.F., M.E.A., L.J.R., J.R.B.), Pathology (V.A.), and Medicine (M.E.A., L.J.R.), Vanderbilt University School of Medicine, Nashville, Tenn; and the Department of Pharmacology (P.A.B.), Columbia University, New York, NY.

* To whom correspondence should be addressed. E-mail: jeff.balser{at}vanderbilt.edu.

Sudden cardiac death attributable to ventricular tachycardia/fibrillation (VF) remains a catastrophic outcome of myocardial ischemia and infarction. At the same time, conventional antagonist drugs targeting ion channels have yielded poor survival benefits. Although pharmacological and genetic models suggest an association between sodium (Na+) channel loss-of-function and sudden cardiac death, molecular mechanisms have not been identified that convincingly link ischemia to Na+ channel dysfunction and ventricular arrhythmias. Because ischemia can evoke the generation of reactive oxygen species, we explored the effect of oxidative stress on Na+ channel function. We show here that oxidative stress reduces Na+ channel availability. Both the general oxidant tert-butyl-hydroperoxide and a specific, highly reactive product of the isoprostane pathway of lipid peroxidation, E2-isoketal, potentiate inactivation of cardiac Na+ channels in HEK-293 cells and cultured atrial (HL-1) myocytes. Furthermore, E2-isoketals were generated in the epicardial border zone of the canine healing infarct, an arrhythmogenic focus where Na+ channels exhibit similar inactivation defects. In addition, we show synergistic functional effects of flecainide, a proarrhythmic Na+ channel blocker, and oxidative stress. These data suggest Na+ channel dysfunction evoked by lipid peroxidation is a candidate mechanism for ischemia-related conduction abnormalities and arrhythmias.
Key words: sodium channels • lipid-peroxidation • isoketals • myocardial infarction




This article has been cited by other articles:


Home page
 Exp. Biol. Med.Home page
K. M. Jaques-Robinson, R. Golfetti, S. S. Baliga, N. M. Hadzimichalis, and G. F. Merrill
Acetaminophen Is Cardioprotective Against H2O2-Induced Injury In Vivo
Experimental Biology and Medicine, October 1, 2008; 233(10): 1315 - 1322.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
B. London, M. Michalec, H. Mehdi, X. Zhu, L. Kerchner, S. Sanyal, P. C. Viswanathan, A. E. Pfahnl, L. L. Shang, M. Madhusudanan, et al.
Mutation in Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias
Circulation, November 13, 2007; 116(20): 2260 - 2268.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
D. W. Van Norstrand, C. R. Valdivia, D. J. Tester, K. Ueda, B. London, J. C. Makielski, and M. J. Ackerman
Molecular and Functional Characterization of Novel Glycerol-3-Phosphate Dehydrogenase 1-Like Gene (GPD1-L) Mutations in Sudden Infant Death Syndrome
Circulation, November 13, 2007; 116(20): 2253 - 2259.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Carnes, P. M. L. Janssen, M. L. Ruehr, H. Nakayama, T. Nakayama, H. Haase, J. A. Bauer, M. K. Chung, I. M. Fearon, A. M. Gillinov, et al.
Atrial Glutathione Content, Calcium Current, and Contractility
J. Biol. Chem., September 21, 2007; 282(38): 28063 - 28073.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
R. B. Neuman, H. L. Bloom, I. Shukrullah, L. A. Darrow, D. Kleinbaum, D. P. Jones, and S. C. Dudley Jr
Oxidative Stress Markers Are Associated with Persistent Atrial Fibrillation
Clin. Chem., September 1, 2007; 53(9): 1652 - 1657.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh
Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation
Physiol Rev, April 1, 2007; 87(2): 425 - 456.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.